Surgical methods to reverse left ventricular remodeling

Michele De Bonis1, Ottavio Alfieri

  • 1Department of Cardiac Surgery, San Raffaele University Hospital, Via Olgettina 60, 20132 Milano, Italy. michele.debonis@hsr.it

Insights

Heart transplantation is limited for end-stage dilated cardiomyopathy. This review covers surgical methods to reverse ventricular remodeling, improving heart failure symptoms and survival.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Research

Background:

  • Heart transplantation is the primary treatment for end-stage dilated cardiomyopathy.
  • Limited donor organs and contraindications restrict transplantation's impact on heart failure.
  • Ventricular remodeling exacerbates systolic heart failure, impacting patient outcomes.

Purpose of the Study:

  • To review surgical interventions for reversing cardiac remodeling in systolic heart failure.
  • To discuss the indications, outcomes, and limitations of current surgical methods.
  • To provide insights into managing heart failure beyond transplantation.

Main Methods:

  • Literature review of conventional surgical procedures for cardiac remodeling.
  • Analysis of studies focusing on ventricular remodeling reversal.
  • Synthesis of data on surgical indications, results, and limitations.

Main Results:

  • Conventional surgical procedures offer alternatives to heart transplantation.
  • These methods aim to mitigate adverse ventricular remodeling.
  • Surgical interventions can improve symptoms and survival in heart failure patients.

Conclusions:

  • Surgical approaches are crucial for managing heart failure when transplantation is not feasible.
  • Understanding the indications and limitations of these surgeries is vital for patient care.
  • Further research into optimizing surgical strategies for cardiac remodeling is warranted.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...